207 related articles for article (PubMed ID: 6441072)
1. [Experience with diamicron treatment of diabetics].
Velikov VK; Shubina IO; Saltykov BB; Frolova AI
Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
[No Abstract] [Full Text] [Related]
2. [Diamicron in the treatment of diabetes mellitus type 2].
Balabolkin MI; Morozova TP; Chachiashvili MV
Sov Med; 1987; (7):21-2. PubMed ID: 3317910
[No Abstract] [Full Text] [Related]
3. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
Rupprecht E; König E; Limmer J
Pol Tyg Lek; 1993 Apr; 48 Suppl 1():31-2. PubMed ID: 8516203
[No Abstract] [Full Text] [Related]
4. [Diamicron and micristin in the complex treatment of diabetes mellitus].
Balabolkin MI; Golubiatnikova GA; Koroleva TV; Titova GP
Ter Arkh; 1982; 54(10):32-6. PubMed ID: 7179117
[No Abstract] [Full Text] [Related]
5. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
Grzeszczak W; Strojek K
Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
[No Abstract] [Full Text] [Related]
6. [Comparative evaluation of the hypoglycemic effect of the 2d-generation sulfonylurea preparations maninil and diamicron in diabetes mellitus].
Balabolkin MI; Morozova TP; Zhizhina SA; Levitskaia ZI; Gincherman LE
Probl Endokrinol (Mosk); 1982; 28(5):9-11. PubMed ID: 6815639
[TBL] [Abstract][Full Text] [Related]
7. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
8. [Value of gliclazide in the treatment of early diabetic retinopathy].
Cabral BV; Fernando R; Villegas-Cinco A; Icasas-Cabral E; Cinco L
Therapie; 1985; 40(4):231-3. PubMed ID: 4024018
[No Abstract] [Full Text] [Related]
9. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
Masbernard A; Portal A
Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
[No Abstract] [Full Text] [Related]
10. [Survey of 832 case records of diabetes of adult onset treated by Diamicron. Evolution of metabolism and weight].
Estivals JP; Giraudet MC; Videau JY
Journ Annu Diabetol Hotel Dieu; 1978; ():333-40. PubMed ID: 349228
[No Abstract] [Full Text] [Related]
11. Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.
Räkel A; Renier G; Roussin A; Buithieu J; Mamputu JC; Serri O
Diabetes Obes Metab; 2007 Jan; 9(1):127-9. PubMed ID: 17199728
[No Abstract] [Full Text] [Related]
12. [Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
Lesobre B
Journ Annu Diabetol Hotel Dieu; 1990; ():325-34. PubMed ID: 2195215
[No Abstract] [Full Text] [Related]
13. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
Simonin R
Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
[No Abstract] [Full Text] [Related]
14. Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality.
Monami M; Balzi D; Lamanna C; Barchielli A; Masotti G; Buiatti E; Marchionni N; Mannucci E
Diabetes Metab Res Rev; 2007 Sep; 23(6):479-84. PubMed ID: 17385195
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus].
Polosa P; Mughini L
Clin Ter; 1978 Jan; 84(2):135-40. PubMed ID: 648096
[No Abstract] [Full Text] [Related]
16. [Hypoglycemic effect of diamicron in diabetic patients].
Balabolkin MI; Morozova TP; Zhizhina SA; Gavriliuk LI
Klin Med (Mosk); 1983 Jan; 61(1):87-9. PubMed ID: 6834765
[No Abstract] [Full Text] [Related]
17. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
[TBL] [Abstract][Full Text] [Related]
18. [Long-term ambulatory treatment of diabetics with gliclazide].
Parodi FA
Clin Ter; 1979 Feb; 88(3):281-8. PubMed ID: 376219
[No Abstract] [Full Text] [Related]
19. 'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas.
Bilinska M; Potocka J; Korzeniowska-Kubacka I; Piotrowicz R
Coron Artery Dis; 2007 Sep; 18(6):455-62. PubMed ID: 17700217
[TBL] [Abstract][Full Text] [Related]
20. Diabetes, coronary heart disease and sulphonylureas-not the final word.
Betteridge DJ; Close L
Eur Heart J; 2000 May; 21(10):790-2. PubMed ID: 10781346
[No Abstract] [Full Text] [Related]
[Next] [New Search]
